The document provides background information on Nigeria's polio eradication efforts. It discusses the establishment of the Global Polio Eradication Initiative in 1988 and Nigeria's declaration of polio as a national public health emergency. It outlines Nigeria's strategies for polio eradication including routine immunization, supplemental immunization campaigns, surveillance of acute flaccid paralysis cases, and inter-agency coordination mechanisms. It also summarizes Nigeria's progress in reducing polio cases from 2013-2015 and ongoing challenges to achieving eradication.
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
Government of India initiated a National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) during 2010-11 after integrating the National Cancer Control Programme (NCCP) with (NPDCS).
National framework for malaria elimination in indiaAparna Chaudhary
outlines India’s strategy for elimination of the disease by 2030. The framework has been developed with a vision to eliminate malaria from the country and contribute to improved health and quality of life and alleviation of poverty.
This presentation contains in brief about various Non-communicable diseases (NCDs) and International interventions to combat NCDs. It also contains recent updates on current problem statement of common NCDs and updates on National Programme for Prevention and Control of non-Communicable Diseases (NP-NCDs).
Dear Doctor,
Its humbling that you liked the presentation and would like to use it for your purpose. Kindly find your requested presentation attached with this email.
The shortlink for your future reference is http://go.drankush.com/PolioFinal
We would always appreciate if you would place this reference as a due credit in your work and while sharing for others use.
Ankush, Amroskar S, Bhamaikar V, Barreto J. "Polio Final Presentation" Accessed from http://go.drankush.com/PolioFinal
-----------------------------------------------------
As we near eradication of this dreaded disease - "POLIO", we would like to share the following presentation we made for our Pediatrics seminar in 2012.
Best attempts have been made to cover most of the topic, keeping the size under 100 slides.
Hope you like it.
Ankush
Shahin Amroskar
Varsha Bhamaikar
Joyce Barreto
National Program for Prevention and Control of Cancer, Diabetes, CVD and Stro...Vivek Varat
Government of India initiated a National Programme for Prevention and Control of Cancers, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) during 2010-11 after integrating the National Cancer Control Programme (NCCP) with (NPDCS).
National framework for malaria elimination in indiaAparna Chaudhary
outlines India’s strategy for elimination of the disease by 2030. The framework has been developed with a vision to eliminate malaria from the country and contribute to improved health and quality of life and alleviation of poverty.
This presentation contains in brief about various Non-communicable diseases (NCDs) and International interventions to combat NCDs. It also contains recent updates on current problem statement of common NCDs and updates on National Programme for Prevention and Control of non-Communicable Diseases (NP-NCDs).
Dear Doctor,
Its humbling that you liked the presentation and would like to use it for your purpose. Kindly find your requested presentation attached with this email.
The shortlink for your future reference is http://go.drankush.com/PolioFinal
We would always appreciate if you would place this reference as a due credit in your work and while sharing for others use.
Ankush, Amroskar S, Bhamaikar V, Barreto J. "Polio Final Presentation" Accessed from http://go.drankush.com/PolioFinal
-----------------------------------------------------
As we near eradication of this dreaded disease - "POLIO", we would like to share the following presentation we made for our Pediatrics seminar in 2012.
Best attempts have been made to cover most of the topic, keeping the size under 100 slides.
Hope you like it.
Ankush
Shahin Amroskar
Varsha Bhamaikar
Joyce Barreto
Introducing NPSP 3.0
Join Kevin Bromer, Director of Product Development, on the new features and functionality of the new Nonprofit Starter Pack 3.0 including: support for multiple and seasonal addresses; a new Household Account model that makes it easier for you to manage households; easier control of settings and configuration through a new centralized NPSP Settings tab; and lots more.
Disorders of the neuromuscular junction include Myasthenia gravis, Lambert-Eaton myasthenic syndrome, Botulism, Tetanus, Strychnine intoxication, Organophosphates poisoning and neuromyotonia. Pharmacology of the NMJ is also reviewed in brief.
2018 polio eradication for bay of plenty grand roundMichelle Tanner
Polio eradication and my personal experiences of being invited to Pakistan as a Rotarian and nurse expert on immunisations, to present at a Rotary polio eradication conference and participate in polio and polio education activities.
“Rachel Glennerster is Executive Director of the Abdul Latif Jameel Poverty Action Lab (J-PAL). HerRachel - Credit Blu Nordgren research includes randomized evaluations of community-driven development, the adoption of new agricultural technologies, and improving the accountability of politicians in Sierra Leone; empowerment of adolescent girls in Bangladesh; and health, governance, education, and microfinance programs in India. She serves as Scientific Director for J-PAL Africa, Co-Chair of J-PAL’s Agriculture Program and is a board member of the Agricultural Technology Adoption Initiative (ATAI). She is the lead academic for Sierra Leone for the International Growth Center. Between 2007 and 2010 she served on the UK Department for International Development’s (DFID) Independent Advisory Committee on Development Impact.
Rachel Glennerster helped establish Deworm the World, of which she is a board member, which has helped deworm 23 million children worldwide. Before joining J-PAL, she worked at the IMF and Her Majesty’s Treasury. She has a Ph.D. in economics from Birkbeck College, University of London. She is coauthor of Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases, and Running Randomized Evaluations.”
common childhood illnesses health-seeking behavior and treatment practices af...JSI
Scaling up integrated community case management (iCCM) to improve child health in local communities in Ethiopia, presentation at the 2015 American Public Health Association (APHA) conference.
The Ethiopia Last 10 Kilometers project is implemented by JSI Research & Training Institute, Inc., and funded by Bill & Melinda Gates Foundation.
Juma Hayombe, a Project Manager with Catholic Medical Mission Board in South Sudan, describes the organization's program to partner with traditional birth attendants to leverage human resources in the resource-limited nation of South Sudan.
The PPT gives overview of PEI, global updates on PEI, Polio end game strategy and eradication timelines, polio legacy and link with Health Systems strengthening and relevant health programes etc. The PPT was presented at National Annual Review Meeting held for 2 days in Mussoorie for Core Group of Polio Project (CGPP) -a USAID funded polio eradication initiatives. ADRA India is one of the lead implementing agency for CGPP since 2004 and it has worked for nearly 15 years in polio across states in India.
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
"Looking Ahead" Post-Ebola Strategy in West Africa is the first in a series of planned webinars, where we invite knowledgeable individuals and participants to join the post-Ebola strategy in West Africa discussion.
During the webinars, experts from different backgrounds, will outline their view on the Ebola Crisis and most importantly, share their vision on what needs to be done now, and post-Ebola, to ensure aversion of further political and economic disturbances.
The fast spread of the Ebola virus has major consequences on the African countries it has hit the hardest: Guinea, Liberia, and Sierra Leone.
Besides the death tolls and associate losses, the countries are also facing great danger because of the economic consequences the virus carries.
Sierra Leone and Liberia, two of the most hit countries, have both recently come out of more than a decade of gruesome civil wars and the set back of the disease does not help with the stabilization of the economies. Their democracies are fragile and the deprivation from the Ebola crisis could be a trigger for political disruption.
The youth played a major role in those conflicts as a result of economic and social marginalization. Without a post-Ebola strategy to ensure the youth a future of economic and social stability, there may be unforeseeable instabilities.
ABOUT THE ORGANIZER:
Twenty-First Century African Youth Movement, (AYM) empowers and mobilizes Africa’s youth through employment. The AYM is dedicated to developing new and exciting enterprise opportunities for young people in Sierra Leone, to help provide young people with the confidence, power and skills they need to get themselves into employment and out of poverty.
Mobilizing Africa’s unemployed and underemployed youth is the key to the continent’s economic growth and stability. AYM works to mobilize marginalized youth through education, training, and employment, creating entrepreneurial opportunities to help move communities away from poverty, disease, and hunger. AYM aims to establish personal empowerment and community resilience by energizing the continent’s youth population, its most critical resource in the reversal of social and economic stagnation.
For more information, visit:
http://www.aym-inc.org/ebola-looking-ahead/.
AYM’s call for action:
Dr David J Baumler’s AYM Pepper Challenge: http://youtu.be/iU1Ot60mT7I
A recent Presentation at National Annual Review Meeting of Core Group Polio Project (CGPP) -USAID funded project, ADRA India: implementing agency with technical support from CORE Secretariat
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Clinician sensitization on afp surveillance & polio eradication program
1. AFP Surveillance & Polio
Eradication Program
By FCT EPI/PEI Team
Sensitization of Nurses during their
Annual conference
2. The Global Polio Eradication Initiative
Background:
• In 1988, the forty-first World Health Assembly,
consisting then of delegates from 166
Member States, adopted a resolution for the
worldwide eradication of polio. It marked the
launch of the Global Polio Eradication
Initiative, spearheaded by WHO, Rotary
International, the US Centers for Disease
Control and Prevention (CDC) and the United
Nations Children’s Fund (UNICEF).
3. 65th World Health Assembly:
"DECLARES polio
eradication….emergency
for global public health"
May 2012
3
4. Strategies to Eradicate Polio
Routine immunization (Given at
birth, 6 weeks, 10 weeks and 14
weeks) –at least 80% coverage
Supplemental Immunization
campaigns (such as house to
house polio vaccination) – at least
90 % Coverage.
Mop-ups - Vaccination of children
living near a confirmed polio case
to prevent spread
Surveillance - Searching
for/reporting to the nearest health
centre all cases of children who
suddenly experience weakness or
paralysis of one or more limbs.
5. 2013 NIGERIA POLIO ERADICATION
EMERGENCY PLAN
• Goal:
The overall goal of the plan is to achieve
interruption of poliovirus transmission in Nigeria
by December 2013
• Focus
• Best people in worst places
• Improve access in zero dose communities
• Sanctuaries
• Early detection and rapid response
6. Strategic Priorities for 2014
1. Containing transmission in the breakthrough LGAs /
States
2. Increasing reach in the security compromised areas
3. Improving quality in persistently poor performing LGAs /
wards
4. Timely and adequate outbreak response
5. Reaching children in underserved populations
6. Intensifying advocacy, community demand and trust
7. Intensifying surveillance
8. Expanding use of technologies
9. Intensifying in-between round activities
7. 2015 Nigeria Polio Eradication Emergency Plan
Target 1: Interruption of WPV transmission by
3rd quarter 2015
Target 2: Zero cVDPV cases in AFP and the
environment by 2nd quarter 2015 and
interruption of cVDPV transmission by end 2015
7
8. Nigeria has convened multi-level polio-focused entities, in collaboration with partner agencies,
to facilitate its polio eradication efforts
Presidential Taskforce
National EOC
State Taskforce
State EOCs
LGA Taskforce
Ward Health CommitteeWard
LGA
State
National
National Polio EOC
▪ Technical assistance (social
mobilization, etc.)
▪ Resource provision
▪ Operational and logistic
support
▪ Advocacy
▪ Community engagement
▪ Advocacy
▪ Operations support
▪ Resource mobilization
▪ Technical assistance (staffing,
NSTOP)
▪ Facilities management
Rotary
club
eHealth
Nigeria
▪ Primary health care support
▪ Technical assistance (staffing,
surge capacity)
9. Coordination mechanisms deployed to ensure
implementation of Plan
• Increased oversight by political and traditional
institutions
– Inauguration of Presidential Task force, State and
LGA Task Forces(march 2012)
– Strenthening of Northern Traditional Leaders
Forum
• Establishment of the National Polio
Emergency Operations Centre (EOC) and 5
State EOCs (October 2012)
10. • Highest level of political commitment
by Mr. President
• Governors of HR States and Chairmen
of 45 vulnerable LGAs met with Mr
President on October 16, 2012
• Advocacy visits to High Risk (HR)
States
• Renewed engagement of traditional
leaders in the supervision of IPDs and
resolution of Non-compliant cases.
• MOU signed with traditional leaders
to personally ensure ownership and
accountability for PEI
Presidential Taskforce Activities
11. …as well as to international border communities
Customs Border station, Jibia, Katsina
Immunization records, Ilela border, Sokoto
Vaccinating children crossing the border
Community interaction at Jega, Kebbi state
12. HE Executive Govenor, Kano HE Executive Governor, Jigawa
12/22/2015 12
Highest level political commitment and advocacy
HE Executive Governor, KebbiHE Executive Governor, Zamfara
13. Social Mobilization at all levels
• Advocacy/sensitization meeting with LGA Chairmen in
each state
• Advocacy meeting with health professionals/ medical
bodies in each state
• Orientation/sensitization meeting with various
stakeholders: e.g.
Traditional leaders
Nigeria Inter-faith Action Association
Leaders of Islamic and Christian bodies (Supreme
Council of Islamic Affairs, Jamatu Nasir Islam,
Christian Association of Nigeria and other
religious bodies
Officials of MDAs.
Youth/women oriented NGOs, CBOs, FOMWAN
STRATEGY: ADVOCACY/SOCIAL MOBILIZATION/PARTNERSHIP ENGAGEMENT
15. Data analysts
Data analysts
Data analysts
Polio Emergency Operations in Nigeria
Abuja EOC
Data analysts
Kano EOC
Presidential Task Force
NPHCDA (Secretariat)
Katsina EOC
Kaduna EOC
Sokoto EOC
Borno EOC
▪ Presidential Task Force established and mandated to drive
emergency response to polio eradication
▪ NPHCDA serves as Secretariat to Task Force and responsible for
implementation of Emergency Plan
▪ Abuja Emergency Operations Center commissioned by
Presidential Task Force as management tool for NPHCDA to
coordinate overall emergency response
▪ Incident Manager (NPHCDA) and Deputy Incident Manger (MOH)
deputized with executive authority by MOSH and ED
▪ All GPEI partners to assign senior staff to EOC
▪ McKinsey recruited to provide strategic and management support
to EOC
▪ State Emergency Ops Centers planned for Kano, Sokoto, Katsina,
Kaduna and Borno
15
17. Trends of WPV1 and WPV3 in Nigeria (2000 – 2015)
17
WPV 3 Interrupted
18. Trend of WPV in Nigeria (2012-2015)
• Strong political support by the
government
• Inception of the EOC in 2012
• Strengthening accountability at
all levels
• The use of innovative strategies
to reach more children
57% reduction
89% reduction
EOC Objective 1: Zero
case
18
19. As at October 23, 2015 Nigeria has
• No confirmed WPV for 2015 compared to 6 cases for the same
period in 2014
– Date of onset of latest WPV1 case is 24 July, 2014
– Date of onset of latest WPV3 case is 10 November, 2012
• One confirmed vaccine derived poliovirus (cVDPV2) for 2015
compared to 27 cases in 5 States for the same period in 2014
– Date of onset of latest cVDPV2 case is 16 May, 2015
Nigeria: Polio cases as at Week 43, 2015
20. Latest onset of confirmed WPV was 24-Jul-2014 from Sumaila LGA, Kano State.
Nigeria: Total Poliovirus 2013 – 2015* cases by
Zones and States
21. Nigeria: Total Poliovirus 2013 - 2015 in Environmental
Samples by Zones and States
Sites were not starting during this period-
22. Nigeria: Polio Compatible Cases Jan – Oct 23, 2014/2015
as at week 43, 2015
2014 2015
Compatibles (n=17)
# Infected State: 11
Compatibles (n=30)
# Infected State: 15
23. Challenges
• Insecurity is the major challenge
• Operational gaps in worse performing LGAs
(poor team performance, supervision)
• Anti polio campaigns
• Accountability at the operational levels
• Unmet needs of the populace
24. 24
• Provide pluses – e.g., soap,
ORS, deworming tablets,
vitamin A, milk sachets are
being provided to during the
May IPD
• Providing bore holes in
communities that have
identified water shortage as
one of their felt needs
• Integrating OPV campaigns with
measles, Men A and Yellow
Fever campaigns; OPV
administered at fixed posts
during campaigns
• Distribution of bed nets as
pluses during IPDs and as
incentive for mothers to
complete immunization
Addressing unmet health needs of communities
and linkage to PEI
Free Drugs by NPHCDA
Provision of Bed netsIntegrating OPV & MCH
Potable water supply
25. VCM newborn tracking, 7 Apr- 12 Jul 2013
14713 new births recorded in VCM network
11337 given 0 dose by or with support of VCM
12239 linked to facility for RI
8980 naming ceremonies attended by VCM
26. Disease Surveillance
Ongoing, systematic collection, analysis,
and interpretation of health-related data
essential for the planning,
implementation, and evaluation of
health practice, closely integrated with
the timely dissemination of these data
to those responsible for prevention and
control.
27. AFP surveillance
What is it?
• detect any case of AFP < 15 years of age and
any case of any age in which a clinician suspects polio
• collect 2 stool specimens at 24 hours interval < 14 days of paralysis onset
• perform virus isolation in a WHO-accredited laboratory
• classify cases according to WHO scheme
28. Acute Flaccid Paralysis
• Acute: sudden onset of new/recent paralysis
– as opposed to chronic (e.g., from birth) or very
gradual onset
• Flaccid: loss of muscle tone, “floppy” (as
opposed to spastic or rigid)
• Paralysis: weakness, loss or diminution of
motion of one or more limbs
29. • Any case of sudden onset of weakness of one
or more limbs in a child <15 years of age
or
• Any case of paralytic illness (regardless of
age) in which a clinician suspects polio
Case Definition for Acute Flaccid Paralysis
(AFP) Surveillance
30. AFP Surveillance Cntd.
•It should be stressed that surveillance is
carried out for all cases of AFP, regardless of
cause.
•Note that it is acute onset of flaccid paralysis
for which no obvious cause (such as severe
injury or birth trauma) is found.
•When in doubt, the case should be reported,
and surveillance officers will investigate and
verify them.
31. Events of AFP Surveillance
Immediate reporting of AFP cases.
Immediate case investigation.
Collection of 2 stool specimens,
Additional case findings (contact-tracing) and
outbreak response immunization (ORI)
60+ Day follow-up examination
Case Classification
32. Acute Flaccid Paralysis
Paresis, Weakness
Floppy limb
Can’t move leg, arm
Can’t walk
Can’t sit-up
Paralysis - sudden onset
Clues to the Presence of AFP Major
Clinical features
33. Acute Flaccid Paralysis
Transverse myelitis
Traumatic neuritis
Guillain -Barre Syndrome
Other enteroviruses
Coxsackie virus
Echovirus
Poliovirus
Differential Diagnosis for AFP
Transient weakness of unknown
cause
34. Overview of Poliomyelitis
Definition of Poliomyelitis:
An endemic virus infection which attacks the motor neurons
of the anterior horns in the brain stem and spinal cord.
An attack may or may not lead to paralysis with loss of
muscular power and flaccidity i.e acute flaccid paralysis
(AFP).
Sensory neurons are not affected so there is still a sense of
feeling in the limb.
When it occurs within two days of vaccination the term
provocative paralytic poliomyelitis is used. This is also known
as Vaccine Activated Paralytic Poliomyelitis (VAPP) and it
occurs in less than 1 in 3 million cases.
Suspected polio is:
Any case of acute flaccid paralysis in a child aged less than
15yrs, including Gullian-Barre syndrome, for which no other
obvious cause such as trauma is evident at onset.
AFP = Sudden loss of strength, tone and/or reflexes in a limb
or limbs – is the indicator of surveillance for Poliomyelitis.
35. EPIDEMIOLOGY
Disease of young children 80 – 90% of cases occur in
children less than 5 yrs old
Cluster of susceptible population is required to maintain
circulation
Seasonal increase in cases in the wet or rainy season May
to July
Silent transmission >99% of cases are sub-clinical /
asymptomatic /carrier state
Risk of paralysis is increased by
Tonsillectomy
Exercise
Pregnancy
I.M Injections
36. Clinical Outcome of Poliovirus Infections
asymptomatic infection
clinical illness, no paralysis
paralytic poliomyelitis
37. CLINICAL FEATURES OF POLIOMYELITIS
Acute onset of flaccid paralysis
Fever, sneezing, runny nose,+/- loose motions
Fatigue, headache, vomiting, and pain in the
limbs
Asymmetric
Legs affected most often
Mortality rate 5 – 10%
Paralysis is permanent
NB: Poliomyelitis is a highly communicable
disease which must be eradicated.
38. What Makes Polio Eradication
Possible
It is found only in human beings. No extra
human reservoir.
Poliovirus is heat sensitive and does not
survive long in the environment, especially
tropical climates like Nigeria
There is no long term carrier state
Fewer than 1% of polio infections ever result
in paralysis
Permanent immunity following infection
OPV is a proven vaccine for eradication
39. POLIO VACCINE
• Protective immunity against polio infection develops by
immunization or natural infection.
• Immunity to one polio virus type (as occurs by natural
immunity) does not protect against infection from other polio
virus types, this is why trivalent vaccination is vital.
• Immunity conferred is lifelong .
• Infants born to mothers with high antibody levels against the
polio virus are protected for the first few days of life but this
is highly inadequate.
• There are two types:
ORAL POLIO VACCINE (OPV)
INACTIVATED POLIO VACCINE(IPV)
40.
41. Some Drawbacks in Polio Eradication
• Poor RI coverage (routine immunization and primary
health care systems are weak).
• Failure to reach enough children during polio
immunization campaigns (missed children – child
absent, non-compliance and households not visited)
• Religious beliefs – Some Muslims do not believe in
disease prevention; some Christians don’t take
medicines.
• Lack of awareness by health care providers on polio
eradication process with particular reference to SIAs
and necessity for multiple/several OPV doses.
• Lack of trust in polio immunization by some sections of
the public – including health workers.
• Lack of commitment some political/traditional leaders
and policy makers at both federal, state and LGAs.
42. FAQ
• What is polio?
• Polio is a highly infectious disease caused by a
virus.
• The virus invades the nervous system, and can
cause total paralysis in a matter of hours.
• In some cases, the poliovirus can even cause death.
• Poliovirus is a communicable disease which cannot
be controlled and therefore must be eradicated.
42
43. Why are there so many rounds of Polio Campaigns in
Nigeria?
• Multiple rounds are necessary to eradicate polio; every child
under 5 years must receive the polio vaccine multiple times,
regardless of previous immunization status.
• The strategy is to immunize children who are either not
immunized, or only partially protected (ie who have not received
sufficient doses of OPV), as well as to boost immunity levels in
those children who have already been immunized.
• It is important to note that these strategies only work if each and
every child is immunized during each and every immunization
campaign. It is the only way to stop the transmission and
circulation of wild poliovirus, and to eradicate the disease once
and for all.
43
44. Key facts
• Polio (poliomyelitis) mainly affects children under five years of age.
• One in 200 infections leads to irreversible paralysis. Among those paralysed,
5% to 10% die when their breathing muscles become immobilized.
• Polio cases have decreased by over 99% since 1988. The reduction is the
result of the global effort to eradicate the disease.
• In 2012, only three countries (Afghanistan, Nigeria and Pakistan) remain
polio-endemic, down from more than 125 in 1988.
• Persistent pockets of polio transmission in northern Nigeria and the border
between Afghanistan and Pakistan are the current focus of the polio
eradication initiative.
• As long as a single child remains infected, children in all countries are at risk
of contracting polio. In 2009-2010, 23 previously polio-free countries were
re-infected due to imports of the virus.
• In most countries, the global effort has expanded capacities to tackle
infectious diseases by building effective surveillance and immunization
systems.
• These efforts can only work if all hands are on deck.
45. Conclusion
What are Nurses required to do?
• Immediately report any case(s) of AFP to HF focal person,
DSNO for the Area Council, FCT State DSNO or WHO
Surveillance officers for prompt case investigation and
verification.
• Support clinicians in diagnosis and complete (traceable)
address of the AFP case in the record book.
• As much as possible, admit all AFP cases immediately.
• Keep the Patient (if possible) until 2 stool specimens are
collected.
• Support the DSNO to collect two stool specimens, 24-48
hours apart; Specimen should reach NPL within 72 hrs of
collection.
• Support the Polio Eradication Initiative by also encouraging
your clients to present eligible children for RI (<1yr) and
SIAs/IPDs (<5yrs).